首页 > 最新文献

Cornea最新文献

英文 中文
Letter Regarding: Analysis of Graft Detachments and Re-Bubblings After 450 Descemet Membrane Endothelial Keratoplasty Procedures. 致编辑的信:450 例 Descemet 膜内皮角膜移植术后移植片脱落和再出血分析。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2025-01-14 DOI: 10.1097/ICO.0000000000003812
Mohit Parekh, Davide Romano, Matteo Airaldi, Alfredo Borgia, Antonio Moramarco, Vito Romano
{"title":"Letter Regarding: Analysis of Graft Detachments and Re-Bubblings After 450 Descemet Membrane Endothelial Keratoplasty Procedures.","authors":"Mohit Parekh, Davide Romano, Matteo Airaldi, Alfredo Borgia, Antonio Moramarco, Vito Romano","doi":"10.1097/ICO.0000000000003812","DOIUrl":"10.1097/ICO.0000000000003812","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e10-e11"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142977653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Descemet Membrane Endothelial Keratoplasty With and Without Graft Deswelling: A Prospective Clinical Study. 有无移植物消肿的 Descemet 膜内皮角膜移植术:前瞻性临床研究。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-03-28 DOI: 10.1097/ICO.0000000000003544
Johannes Menzel-Severing, Jennifer Prues-Hölscher, Lukas Jürgens, Gerd Geerling

Purpose: The purpose of this study was to assess whether omission of dextran from corneal organ culture medium alters the outcome of Descemet membrane endothelial keratoplasty.

Methods: Participation in this single-center, multisurgeon, prospective, randomized, comparative clinical trial was offered to patients scheduled for Descemet membrane endothelial keratoplasty between April 2020 and May 2022. Patients received grafts from corneas deswollen in organ culture medium-containing 6% dextran T-500 or from corneas that were not deswollen. Corrected distance visual acuity (CDVA), graft detachment, central corneal thickness (CCT), and corneal endothelial cell counts were measured at different time points up to 12 months postoperatively.

Results: Grafts stored with dextran were transplanted in 92 patients, and grafts stored without dextran were transplanted in 102 patients. Mean donor age and endothelial cell counts did not differ significantly between both groups. Mean (±SD) postmortem time in hours was 23.9 ± 11.8 in grafts that were deswollen and 28.2 ± 13.8 in grafts that were not deswollen ( P = 0.02). The groups did not show any significant difference at baseline regarding sex, CDVA, or CCT. In the group with dextran, patients had a mean age of 72.5 ± 9.9 years versus 69.5 ± 8.7 in the group without dextran ( P = 0.03). CDVA improved and CCT decreased significantly in both groups. No differences were detected between the groups regarding CDVA, CCT, endothelial cell counts, or rebubbling rates.

Conclusions: This study did not detect any evidence that the omission of dextran from organ culture medium negatively affects the outcomes of Descemet membrane endothelial keratoplasty.

目的:本研究旨在评估角膜器官培养基中不添加葡聚糖是否会改变德斯密特膜内皮角膜移植术的结果:在 2020 年 4 月至 2022 年 5 月期间,计划接受 Descemet 膜内皮角膜移植术的患者均可参加这项单中心、多外科医师、前瞻性、随机、比较临床试验。患者接受的移植物来自在含 6% 右旋糖酐 T-500 的器官培养基中消肿的角膜或未消肿的角膜。在术后12个月内的不同时间点测量了矫正远视力(CDVA)、移植物脱离、角膜中央厚度(CCT)和角膜内皮细胞计数:结果:92 名患者移植了使用葡聚糖保存的移植物,102 名患者移植了未使用葡聚糖保存的移植物。两组供体的平均年龄和内皮细胞计数无明显差异。去肿移植物的平均(±SD)尸检时间为(23.9 ± 11.8)小时,未去肿移植物的平均(±SD)尸检时间为(28.2 ± 13.8)小时(P = 0.02)。两组在性别、CDVA或CCT方面没有明显的基线差异。使用右旋糖酐组患者的平均年龄为(72.5 ± 9.9)岁,而未使用右旋糖酐组患者的平均年龄为(69.5 ± 8.7)岁(P = 0.03)。两组患者的 CDVA 均有明显改善,CCT 均有明显下降。两组在 CDVA、CCT、内皮细胞计数或回泡率方面均未发现差异:本研究没有发现任何证据表明,器官培养基中不添加葡聚糖会对 Descemet 膜内皮角膜移植术的效果产生负面影响。
{"title":"Descemet Membrane Endothelial Keratoplasty With and Without Graft Deswelling: A Prospective Clinical Study.","authors":"Johannes Menzel-Severing, Jennifer Prues-Hölscher, Lukas Jürgens, Gerd Geerling","doi":"10.1097/ICO.0000000000003544","DOIUrl":"10.1097/ICO.0000000000003544","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to assess whether omission of dextran from corneal organ culture medium alters the outcome of Descemet membrane endothelial keratoplasty.</p><p><strong>Methods: </strong>Participation in this single-center, multisurgeon, prospective, randomized, comparative clinical trial was offered to patients scheduled for Descemet membrane endothelial keratoplasty between April 2020 and May 2022. Patients received grafts from corneas deswollen in organ culture medium-containing 6% dextran T-500 or from corneas that were not deswollen. Corrected distance visual acuity (CDVA), graft detachment, central corneal thickness (CCT), and corneal endothelial cell counts were measured at different time points up to 12 months postoperatively.</p><p><strong>Results: </strong>Grafts stored with dextran were transplanted in 92 patients, and grafts stored without dextran were transplanted in 102 patients. Mean donor age and endothelial cell counts did not differ significantly between both groups. Mean (±SD) postmortem time in hours was 23.9 ± 11.8 in grafts that were deswollen and 28.2 ± 13.8 in grafts that were not deswollen ( P = 0.02). The groups did not show any significant difference at baseline regarding sex, CDVA, or CCT. In the group with dextran, patients had a mean age of 72.5 ± 9.9 years versus 69.5 ± 8.7 in the group without dextran ( P = 0.03). CDVA improved and CCT decreased significantly in both groups. No differences were detected between the groups regarding CDVA, CCT, endothelial cell counts, or rebubbling rates.</p><p><strong>Conclusions: </strong>This study did not detect any evidence that the omission of dextran from organ culture medium negatively affects the outcomes of Descemet membrane endothelial keratoplasty.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"418-421"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140335079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal Backscatter, Pachymetric Indices, and Ectasia Indices for the Assessment of Fuchs Endothelial Corneal Dystrophy. 用于评估福氏内皮性角膜营养不良症的角膜反向散射、厚度指数和外伤指数。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-05-28 DOI: 10.1097/ICO.0000000000003577
Sanjay V Patel, David O Hodge, Keith H Baratz

Purpose: To determine whether corneal backscatter, pachymetric indices, and ectasia indices derived from Scheimpflug tomography can identify Fuchs endothelial corneal dystrophy (FECD) corneas with abnormal tomography, the relationships between these parameters and tomographic edema in FECD, and if these parameters help predict improvement in central corneal thickness (CCT) after Descemet membrane endothelial keratoplasty (DMEK).

Methods: Tomography maps of 132 eyes of 80 subjects with FECD were analyzed to determine how backscatter, pachymetric, and ectasia parameters compared with the instrument's normative database and if any predicted tomographic edema. Tomography maps from a separate group undergoing DMEK were split into derivation (48 eyes of 39 subjects) and validation (45 eyes of 41 subjects) subgroups to derive a predictive model of improvement in CCT after DMEK. Backscatter, pachymetric, and ectasia parameters were incorporated to determine if the model could be enhanced.

Results: Among all ectasia, pachymetric, and backscatter parameters, at best only 65% of FECD corneas with definite tomographic edema could be identified based on the instrument's normative database. Among all parameters individually, the highest sensitivity for detecting tomographic edema was 77%. Anterior and mid-corneal backscatter featured in a model predicting improvement in CCT after DMEK with high performance in derivation (R 2 = 0.79; 95% confidence interval, 0.65-0.87) and validation (R 2 = 0.72; 95% confidence interval, 0.52-0.83) subgroups.

Conclusions: The Scheimpflug camera software program could not reliably detect abnormal tomography in FECD from corneal backscatter, pachymetric indices, or ectasia indices. Corneal backscatter contributes to, but does not enhance, a predictive model of improvement in CCT after DMEK.

目的:确定从 Scheimpflug 层析成像中得出的角膜反向散射、厚度指数和外生殖器指数是否能识别层析成像异常的福氏内皮角膜营养不良症(FECD)角膜,这些参数与 FECD 角膜层析水肿之间的关系,以及这些参数是否有助于预测 Descemet 膜内皮角膜移植术(DMEK)后中央角膜厚度(CCT)的改善情况:对 80 名 FECD 患者 132 只眼睛的断层扫描图进行分析,以确定背向散射、测厚和外生殖器参数与仪器标准数据库的比较情况,以及是否有任何参数可预测断层扫描水肿。接受 DMEK 的另一组患者的断层成像图被分成推导(39 名受试者的 48 只眼睛)和验证(41 名受试者的 45 只眼睛)两组,以得出 DMEK 后 CCT 改善的预测模型。结果显示:在所有外生殖器中,瞳孔散射参数、瞳孔厚度参数和外生殖器参数是最重要的:结果:在所有外生殖器、角膜厚度和背向散射参数中,根据仪器的标准数据库,最多只能确定 65% 的 FECD 角膜有明确的断层水肿。在所有参数中,检测断层水肿的灵敏度最高,为 77%。角膜前部和中部的反向散射是预测DMEK术后CCT改善情况的模型特征,在推导(R2=0.79;95%置信区间,0.65-0.87)和验证(R2=0.72;95%置信区间,0.52-0.83)亚组中表现优异:Scheimpflug照相机软件程序无法从角膜后散射、角膜厚度指数或外生殖器指数中可靠地检测出FECD的异常断层扫描。角膜反向散射有助于但并不能增强DMEK术后CCT改善的预测模型。
{"title":"Corneal Backscatter, Pachymetric Indices, and Ectasia Indices for the Assessment of Fuchs Endothelial Corneal Dystrophy.","authors":"Sanjay V Patel, David O Hodge, Keith H Baratz","doi":"10.1097/ICO.0000000000003577","DOIUrl":"10.1097/ICO.0000000000003577","url":null,"abstract":"<p><strong>Purpose: </strong>To determine whether corneal backscatter, pachymetric indices, and ectasia indices derived from Scheimpflug tomography can identify Fuchs endothelial corneal dystrophy (FECD) corneas with abnormal tomography, the relationships between these parameters and tomographic edema in FECD, and if these parameters help predict improvement in central corneal thickness (CCT) after Descemet membrane endothelial keratoplasty (DMEK).</p><p><strong>Methods: </strong>Tomography maps of 132 eyes of 80 subjects with FECD were analyzed to determine how backscatter, pachymetric, and ectasia parameters compared with the instrument's normative database and if any predicted tomographic edema. Tomography maps from a separate group undergoing DMEK were split into derivation (48 eyes of 39 subjects) and validation (45 eyes of 41 subjects) subgroups to derive a predictive model of improvement in CCT after DMEK. Backscatter, pachymetric, and ectasia parameters were incorporated to determine if the model could be enhanced.</p><p><strong>Results: </strong>Among all ectasia, pachymetric, and backscatter parameters, at best only 65% of FECD corneas with definite tomographic edema could be identified based on the instrument's normative database. Among all parameters individually, the highest sensitivity for detecting tomographic edema was 77%. Anterior and mid-corneal backscatter featured in a model predicting improvement in CCT after DMEK with high performance in derivation (R 2 = 0.79; 95% confidence interval, 0.65-0.87) and validation (R 2 = 0.72; 95% confidence interval, 0.52-0.83) subgroups.</p><p><strong>Conclusions: </strong>The Scheimpflug camera software program could not reliably detect abnormal tomography in FECD from corneal backscatter, pachymetric indices, or ectasia indices. Corneal backscatter contributes to, but does not enhance, a predictive model of improvement in CCT after DMEK.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"427-434"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic Therapy for Long-Term Ocular Discomfort After Cataract Surgery. 白内障手术后长期眼部不适的预防性疗法。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-05-17 DOI: 10.1097/ICO.0000000000003561
Antonio Di Zazzo, Sara Spelta, Alessandra Micera, Chiara De Gregorio, Marzia Affatato, Graziana Esposito, Bijorn Omar Balzamino, Roberto Sgrulletta, Marco Coassin, Stefano Bonini

Purpose: The cataract surgery dissatisfaction rate is 20% to 35% due to ocular surface discomfort. We investigate the ocular surface discomfort after surgical failure as a consequence of age-related parainflammation. We also aim to prevent it by immune-modulating prophylactic management.

Methods: Monocentric clinical trial realized in a teaching hospital. Prospective, randomized, open-label, unmasked clinical trial. One hundred patients diagnosed with cataracts underwent phacoemulsification surgery. Groups A (<65 years; n = 25) and B (>75 years; n = 25) received surgery only. Groups C and D (both >75 years and both n = 25) used cyclosporine A 0.1% cationic emulsion (CE) eye drops or CE lubricating eye drops (both twice daily), respectively, for 30 days before surgery. Patients were followed up 90 days after surgery. The primary outcome was postoperative ocular surface failure; secondary outcomes examined the influence of prophylactic cyclosporine A 0.1% CE therapy on ocular surface outcomes.

Results: Group B demonstrated greater severity regarding ocular surface signs and symptoms throughout the study period, versus all other groups. Signs/symptoms were typically lower in Group A. Group C achieved significant reductions in conjunctival Symptom Assessment in Dry Eye values ( P < 0.05), conjunctival hyperemia severity ( P < 0.01), and meibomian gland dysfunction ( P < 0.001) at Day 45, versus Group B, and tear break-up time was increased ( P < 0.001). Ocular surface inflammatory marker transcription (HLADR, intercellular adhesion molecule 1 [ICAM-1], and interleukin 6 [IL-6]) was significantly downregulated in Group C, versus Group B, at 90 days ( P < 0.05).

Conclusions: Cataract surgery induced ocular surface system failure with a clinically significant persistent inflammatory status (InflammAging) in patients older than 75 years. Prophylactic cyclosporine A 0.1% CE eye drops were associated with improved ocular surface homeostasis and reductions in inflammatory markers.

目的:由于眼表不适,白内障手术的不满意率为 20% 至 35%。我们研究了手术失败后的眼表不适是与年龄相关的副炎症的结果。我们的目的还在于通过免疫调节预防性治疗来防止这种情况的发生:方法:在一家教学医院开展的单中心临床试验。前瞻性、随机、开放标签、无掩蔽临床试验。100名白内障患者接受了超声乳化手术。A 组(75 岁;n = 25)只接受了手术。C组和D组(年龄均大于75岁,人数均为25人)在手术前30天分别使用环孢素A 0.1%阳离子乳剂(CE)滴眼液或CE润滑滴眼液(均为每天两次)。术后 90 天对患者进行随访。主要结果为术后眼表失败;次要结果为预防性环孢素 A 0.1% CE 治疗对眼表结果的影响:结果:在整个研究期间,B组与其他各组相比,眼表体征和症状更为严重。与 B 组相比,C 组在第 45 天显著降低了结膜干眼症症状评估值(P < 0.05)、结膜充血严重程度(P < 0.01)和睑板腺功能障碍(P < 0.001),泪液破裂时间延长(P < 0.001)。90天时,C组与B组相比,眼表炎症标志物转录(HLADR、细胞间粘附分子1 [ICAM-1]和白细胞介素6 [IL-6])显著下调(P < 0.05):结论:白内障手术会诱发眼表系统衰竭,在 75 岁以上的患者中会出现具有临床意义的持续炎症状态(InflammAging)。预防性环孢素 A 0.1% CE 滴眼液可改善眼表平衡并降低炎症指标。
{"title":"Prophylactic Therapy for Long-Term Ocular Discomfort After Cataract Surgery.","authors":"Antonio Di Zazzo, Sara Spelta, Alessandra Micera, Chiara De Gregorio, Marzia Affatato, Graziana Esposito, Bijorn Omar Balzamino, Roberto Sgrulletta, Marco Coassin, Stefano Bonini","doi":"10.1097/ICO.0000000000003561","DOIUrl":"10.1097/ICO.0000000000003561","url":null,"abstract":"<p><strong>Purpose: </strong>The cataract surgery dissatisfaction rate is 20% to 35% due to ocular surface discomfort. We investigate the ocular surface discomfort after surgical failure as a consequence of age-related parainflammation. We also aim to prevent it by immune-modulating prophylactic management.</p><p><strong>Methods: </strong>Monocentric clinical trial realized in a teaching hospital. Prospective, randomized, open-label, unmasked clinical trial. One hundred patients diagnosed with cataracts underwent phacoemulsification surgery. Groups A (<65 years; n = 25) and B (>75 years; n = 25) received surgery only. Groups C and D (both >75 years and both n = 25) used cyclosporine A 0.1% cationic emulsion (CE) eye drops or CE lubricating eye drops (both twice daily), respectively, for 30 days before surgery. Patients were followed up 90 days after surgery. The primary outcome was postoperative ocular surface failure; secondary outcomes examined the influence of prophylactic cyclosporine A 0.1% CE therapy on ocular surface outcomes.</p><p><strong>Results: </strong>Group B demonstrated greater severity regarding ocular surface signs and symptoms throughout the study period, versus all other groups. Signs/symptoms were typically lower in Group A. Group C achieved significant reductions in conjunctival Symptom Assessment in Dry Eye values ( P < 0.05), conjunctival hyperemia severity ( P < 0.01), and meibomian gland dysfunction ( P < 0.001) at Day 45, versus Group B, and tear break-up time was increased ( P < 0.001). Ocular surface inflammatory marker transcription (HLADR, intercellular adhesion molecule 1 [ICAM-1], and interleukin 6 [IL-6]) was significantly downregulated in Group C, versus Group B, at 90 days ( P < 0.05).</p><p><strong>Conclusions: </strong>Cataract surgery induced ocular surface system failure with a clinically significant persistent inflammatory status (InflammAging) in patients older than 75 years. Prophylactic cyclosporine A 0.1% CE eye drops were associated with improved ocular surface homeostasis and reductions in inflammatory markers.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"443-449"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140955867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Results of Sterile Corneal Allograft Ring Segments Implantation in Keratoconus Treatment. 无菌角膜异体环段植入治疗角膜炎的长期效果。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-06-18 DOI: 10.1097/ICO.0000000000003592
Fatma Feyza Nur Keskin Perk, Cafer Tanriverdi, Zeki Yigit Karaca, Khoa D Tran, Aylin Kilic

Purpose: To evaluate the efficacy and safety of sterile corneal allograft ring segments implantation for the treatment of keratoconus by analyzing long-term visual, refractive, and tomographic clinical outcomes.

Methods: This prospective study included 62 eyes of 49 patients with keratoconus who underwent corneal allograft ring segments implantation at Istanbul Medipol University Faculty of Medicine between February 2020 and August 2022. Surgical outcomes using the Istanbul nomogram were evaluated in patients preoperatively and postoperatively at 1 month, 6 months, 1 year, and 3 years. Outcomes measured were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent (SE), spherical refraction (SR), cylindrical refraction (CR), topographic keratometric values, and corneal thickness at the thinnest point.

Results: Preoperative mean UDVA and CDVA (LogMAR) were 0.96 ± 0.50 and 0.72 ± 0.47, respectively, and increased to 0.41 ± 0.34 and 0.22 ± 0.19 at the last visit ( P < 0.001). There was a significant decrease in SE, SR, and keratometric values postoperatively ( P < 0.001). There was no difference in CR and thinnest corneal thickness values ( P = 0.333 and 0.154, respectively). The stromal and epithelial thicknesses measured by anterior segment optical coherence tomography were stabilized at 6 months and 1 year, respectively. No major complications or side effects were observed intraoperatively or postoperatively.

Conclusions: This study demonstrated that sterile corneal allograft ring segments implantation is a safe and feasible treatment for keratoconus, yielding notable long-term visual outcomes with minimal implant-related complications.

目的:通过分析长期视力、屈光和断层扫描临床结果,评估无菌角膜异体移植环段植入术治疗角膜炎的有效性和安全性:这项前瞻性研究纳入了伊斯坦布尔梅迪波尔大学医学院在 2020 年 2 月至 2022 年 8 月期间接受角膜异位移植环段植入术的 49 名角膜炎患者的 62 只眼睛。使用伊斯坦布尔提名图对患者术前和术后 1 个月、6 个月、1 年和 3 年的手术效果进行评估。测量的结果包括未矫正远距离视力(UDVA)、矫正远距离视力(CDVA)、球面等效视力(SE)、球面屈光度(SR)、圆柱屈光度(CR)、地形角膜测量值和最薄处的角膜厚度:术前平均 UDVA 和 CDVA(LogMAR)分别为 0.96 ± 0.50 和 0.72 ± 0.47,最后一次就诊时分别增至 0.41 ± 0.34 和 0.22 ± 0.19(P < 0.001)。术后,SE、SR 和角膜测量值明显下降(P < 0.001)。CR 值和最薄角膜厚度值没有差异(P = 0.333 和 0.154)。前段光学相干断层扫描测量的基质厚度和上皮厚度分别在 6 个月和 1 年后趋于稳定。术中和术后均未发现重大并发症或副作用:这项研究表明,无菌角膜异体角膜环段植入术是一种安全可行的角膜病治疗方法,可获得显著的长期视觉效果,且植入相关并发症极少。
{"title":"Long-Term Results of Sterile Corneal Allograft Ring Segments Implantation in Keratoconus Treatment.","authors":"Fatma Feyza Nur Keskin Perk, Cafer Tanriverdi, Zeki Yigit Karaca, Khoa D Tran, Aylin Kilic","doi":"10.1097/ICO.0000000000003592","DOIUrl":"10.1097/ICO.0000000000003592","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the efficacy and safety of sterile corneal allograft ring segments implantation for the treatment of keratoconus by analyzing long-term visual, refractive, and tomographic clinical outcomes.</p><p><strong>Methods: </strong>This prospective study included 62 eyes of 49 patients with keratoconus who underwent corneal allograft ring segments implantation at Istanbul Medipol University Faculty of Medicine between February 2020 and August 2022. Surgical outcomes using the Istanbul nomogram were evaluated in patients preoperatively and postoperatively at 1 month, 6 months, 1 year, and 3 years. Outcomes measured were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent (SE), spherical refraction (SR), cylindrical refraction (CR), topographic keratometric values, and corneal thickness at the thinnest point.</p><p><strong>Results: </strong>Preoperative mean UDVA and CDVA (LogMAR) were 0.96 ± 0.50 and 0.72 ± 0.47, respectively, and increased to 0.41 ± 0.34 and 0.22 ± 0.19 at the last visit ( P < 0.001). There was a significant decrease in SE, SR, and keratometric values postoperatively ( P < 0.001). There was no difference in CR and thinnest corneal thickness values ( P = 0.333 and 0.154, respectively). The stromal and epithelial thicknesses measured by anterior segment optical coherence tomography were stabilized at 6 months and 1 year, respectively. No major complications or side effects were observed intraoperatively or postoperatively.</p><p><strong>Conclusions: </strong>This study demonstrated that sterile corneal allograft ring segments implantation is a safe and feasible treatment for keratoconus, yielding notable long-term visual outcomes with minimal implant-related complications.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"475-482"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idiopathic Fusarium Sclerouveitis: A Case Report. 特发性镰刀菌硬泡炎:病例报告
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-08-29 DOI: 10.1097/ICO.0000000000003689
Akaanksh Shetty, Drew Baeza, Guillermo Amescua, Anat Galor

Purpose: To report a successfully managed case of idiopathic Fusarium sclerouveitis in a healthy patient with no identifiable risk factors.

Methods: We describe a case of a 79-year-old man who presented with right-sided eye, facial, and head pain. Initial examination revealed temporal scleral thinning, inflammation, and anterior chamber cell/flare. Cultures were positive for Fusarium species.

Results: The patient was treated with sub-Tenon amphotericin, intrascleral voriconazole, surgical debridement, Rose Bengal photodynamic therapy, systemic voriconazole and posaconazole, and topical natamycin. The infection resolved and the patient's visual acuity improved to 20/40.

Conclusions: Fusarium sclerouveitis can occur without clear risk factors. This case highlights the importance of an aggressive, multimodal treatment approach for successful management.

目的:报告一例成功治愈的特发性镰刀菌性硬脑膜炎病例,患者健康,无可辨认的危险因素:我们描述了一例因右侧眼部、面部和头部疼痛而就诊的 79 岁男性病例。初步检查发现颞巩膜变薄、炎症和前房细胞/炎症。化验结果为镰刀菌阳性:患者接受了天疱疮下两性霉素、巩膜内伏立康唑、手术清创、Rose Bengal 光动力疗法、全身用伏立康唑和泊沙康唑以及外用纳他霉素等治疗。感染缓解后,患者的视力提高到了 20/40:结论:镰刀菌性硬泡炎可以在没有明确风险因素的情况下发生。本病例强调了积极的多模式治疗方法对成功治疗的重要性。
{"title":"Idiopathic Fusarium Sclerouveitis: A Case Report.","authors":"Akaanksh Shetty, Drew Baeza, Guillermo Amescua, Anat Galor","doi":"10.1097/ICO.0000000000003689","DOIUrl":"10.1097/ICO.0000000000003689","url":null,"abstract":"<p><strong>Purpose: </strong>To report a successfully managed case of idiopathic Fusarium sclerouveitis in a healthy patient with no identifiable risk factors.</p><p><strong>Methods: </strong>We describe a case of a 79-year-old man who presented with right-sided eye, facial, and head pain. Initial examination revealed temporal scleral thinning, inflammation, and anterior chamber cell/flare. Cultures were positive for Fusarium species.</p><p><strong>Results: </strong>The patient was treated with sub-Tenon amphotericin, intrascleral voriconazole, surgical debridement, Rose Bengal photodynamic therapy, systemic voriconazole and posaconazole, and topical natamycin. The infection resolved and the patient's visual acuity improved to 20/40.</p><p><strong>Conclusions: </strong>Fusarium sclerouveitis can occur without clear risk factors. This case highlights the importance of an aggressive, multimodal treatment approach for successful management.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"514-516"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondria-Targeted Antioxidant (MitoQ) and Nontargeted Antioxidant (Idebenone) Mitigate Mitochondrial Dysfunction in Corneal Endothelial Cells. 线粒体靶向抗氧化剂(MitoQ)和非靶向抗氧化剂(依地苯酮)减轻角膜内皮细胞线粒体功能障碍。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2025-01-17 DOI: 10.1097/ICO.0000000000003801
Myriam Böhm, Mohit Parekh, Neha Deshpande, Queenie Cheung, Nathan Shatz, Varun Kumar, Ula V Jurkunas

Purpose: To investigate the effectiveness of mitochondrial-targeted antioxidant mitoquinone (MitoQ) and nontargeted antioxidant idebenone (Idb) in alleviating mitochondrial dysfunction in corneal endothelial cells (CEnCs).

Methods: In vitro experiments were conducted using immortalized normal human corneal endothelial cells (HCEnC-21T; SVN1-67F) and Fuchs endothelial corneal dystrophy (FECD) cells (SVF5-54F; SVF3-76M). Cells were pretreated with MitoQ or Idb and then exposed to menadione (MN) with simultaneous antioxidant treatment. Mitochondrial parameters were evaluated through adenosine triphosphate viability assays, JC-1 staining for mitochondrial membrane potential, and Tom-20 antibody staining for fragmentation, with analysis performed using ImageJ software. HCEnC-21T cells were additionally exposed to ultraviolet-A (25 J/cm 2 ) to assess drug effects under physiological stress. Mitochondrial fragmentation in FECD specimens was analyzed pre- and post-treatment with the drugs. Statistical analysis was conducted using 1-/2-way analysis of variance with post-hoc Tukey test.

Results: MitoQ and Idb enhanced cell viability and mitochondrial membrane potential in both normal and FECD cells under MN-induced stress. Idb reduced MN-induced mitochondrial fragmentation by 32% more than MitoQ in HCEnC-21T cells and by 13% more in SVF5-54F cells. Under ultraviolet-A stress, Idb and MitoQ improved mitochondrial function by 31% and 25%, respectively, with MitoQ increasing mitochondrial function by 42% in FECD specimens.

Conclusions: Differential responses in mitochondrial dysfunction across cell lines highlight disease heterogeneity. MitoQ and Idb protected CEnCs from oxidative stress and improved mitochondrial bioenergetics, suggesting that mitochondrial-targeted antioxidants could be considered for mitochondrial dysfunction in CEnCs.

目的:探讨线粒体靶向抗氧化剂mitoquinone (MitoQ)和非靶向抗氧化剂idebenone (Idb)在缓解角膜内皮细胞(CEnCs)线粒体功能障碍中的作用。方法:采用永生化人正常角膜内皮细胞(hcencc - 21t;SVN1-67F)和Fuchs角膜内皮营养不良(FECD)细胞(SVF5-54F;svf3 - 76米)。细胞用MitoQ或Idb预处理,然后暴露于menadione (MN),同时进行抗氧化处理。通过三磷酸腺苷活力测定、JC-1染色检测线粒体膜电位、Tom-20抗体染色检测碎片化,评估线粒体参数,并使用ImageJ软件进行分析。将hcencc - 21t细胞额外暴露于25 J/cm2的紫外线下,以评估生理应激下的药物作用。分析药物治疗前后FECD标本线粒体断裂情况。统计学分析采用1-/2-way方差分析和事后Tukey检验。结果:在mn诱导的应激下,MitoQ和Idb均能增强正常细胞和FECD细胞的细胞活力和线粒体膜电位。在hcc - 21t细胞中,Idb比MitoQ更能减少mn诱导的线粒体断裂,比MitoQ多32%,在SVF5-54F细胞中多13%。在紫外- a胁迫下,Idb和MitoQ分别提高了31%和25%的线粒体功能,其中MitoQ使FECD标本线粒体功能提高了42%。结论:不同细胞系线粒体功能障碍的差异反应突出了疾病的异质性。MitoQ和Idb可以保护CEnCs免受氧化应激并改善线粒体生物能量,这表明线粒体靶向抗氧化剂可能被认为是CEnCs线粒体功能障碍的原因。
{"title":"Mitochondria-Targeted Antioxidant (MitoQ) and Nontargeted Antioxidant (Idebenone) Mitigate Mitochondrial Dysfunction in Corneal Endothelial Cells.","authors":"Myriam Böhm, Mohit Parekh, Neha Deshpande, Queenie Cheung, Nathan Shatz, Varun Kumar, Ula V Jurkunas","doi":"10.1097/ICO.0000000000003801","DOIUrl":"10.1097/ICO.0000000000003801","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the effectiveness of mitochondrial-targeted antioxidant mitoquinone (MitoQ) and nontargeted antioxidant idebenone (Idb) in alleviating mitochondrial dysfunction in corneal endothelial cells (CEnCs).</p><p><strong>Methods: </strong>In vitro experiments were conducted using immortalized normal human corneal endothelial cells (HCEnC-21T; SVN1-67F) and Fuchs endothelial corneal dystrophy (FECD) cells (SVF5-54F; SVF3-76M). Cells were pretreated with MitoQ or Idb and then exposed to menadione (MN) with simultaneous antioxidant treatment. Mitochondrial parameters were evaluated through adenosine triphosphate viability assays, JC-1 staining for mitochondrial membrane potential, and Tom-20 antibody staining for fragmentation, with analysis performed using ImageJ software. HCEnC-21T cells were additionally exposed to ultraviolet-A (25 J/cm 2 ) to assess drug effects under physiological stress. Mitochondrial fragmentation in FECD specimens was analyzed pre- and post-treatment with the drugs. Statistical analysis was conducted using 1-/2-way analysis of variance with post-hoc Tukey test.</p><p><strong>Results: </strong>MitoQ and Idb enhanced cell viability and mitochondrial membrane potential in both normal and FECD cells under MN-induced stress. Idb reduced MN-induced mitochondrial fragmentation by 32% more than MitoQ in HCEnC-21T cells and by 13% more in SVF5-54F cells. Under ultraviolet-A stress, Idb and MitoQ improved mitochondrial function by 31% and 25%, respectively, with MitoQ increasing mitochondrial function by 42% in FECD specimens.</p><p><strong>Conclusions: </strong>Differential responses in mitochondrial dysfunction across cell lines highlight disease heterogeneity. MitoQ and Idb protected CEnCs from oxidative stress and improved mitochondrial bioenergetics, suggesting that mitochondrial-targeted antioxidants could be considered for mitochondrial dysfunction in CEnCs.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"492-503"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Technique to Close Stellate Corneal Lacerations. 缝合星状角膜裂伤的新技术
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-10-29 DOI: 10.1097/ICO.0000000000003730
Steven E Brooks, Alex Johnson, Emily A Kreuger

Purpose: The study was performed to evaluate and optimize a novel technique to close stellate corneal lacerations in a wet laboratory environment.

Materials and methods: Twenty-one ex vivo porcine eyes with standardized, experimentally created stellate corneal lacerations were assigned to one of three surgical repair techniques. In Group 1 (n = 9), lacerations were closed with simple interrupted sutures only. In Group 2 (n = 7), a large-radius central purse string was used in addition to simple interrupted sutures. In Group 3 (n = 5), a small-radius central purse string was used in addition to simple interrupted sutures. Wound stability was assessed by determining the intraocular pressure (IOP) at which wound leak occurred.

Results: Group 3 eyes demonstrated a mean wound leak IOP of 56.1 mm Hg (range 32-90.3) compared with groups 1 and 2, which demonstrated mean wound leak IOPs of 6.4 mm Hg (range 1.9-19) and 13.3 mm Hg (range 2.8-31), respectively. These differences were highly statistically significant ( P  < 0.002 and P  < 0.015, respectively, compared with Group 3).

Discussion: The use of a small-radius internal purse-string suture, when combined with simple interrupted sutures, produced a highly effective watertight closure in experimentally created stellate corneal lacerations, significantly outperforming approaches using only interrupted sutures or a large-radius purse string. The use of a small-radius purse-string suture should be considered for clinical use in the repair of stellate corneal lacerations.

目的:本研究旨在评估和优化在湿实验室环境下闭合星状角膜裂伤的新技术:21 只活体猪眼睛上的星状角膜裂伤是通过实验制作的标准化角膜裂伤,我们将其分配给三种手术修复技术中的一种。第一组(9 人)仅用简单的间断缝合法缝合裂口。第二组(n = 7)在简单间断缝合的基础上,使用大半径中央缝合线。在第 3 组(n = 5)中,除了简单间断缝合外,还使用了小半径中央荷包线。通过确定发生伤口渗漏时的眼压来评估伤口的稳定性:结果:第 3 组的平均伤口渗漏眼压为 56.1 毫米汞柱(范围为 32-90.3),而第 1 组和第 2 组的平均伤口渗漏眼压分别为 6.4 毫米汞柱(范围为 1.9-19)和 13.3 毫米汞柱(范围为 2.8-31)。这些差异具有高度统计学意义(P 讨论):使用小半径内荷包线缝合,再加上简单的间断缝合,可在实验性星状角膜裂伤中实现高效的水密性闭合,明显优于仅使用间断缝合或大半径荷包线的方法。在修复星状角膜裂伤的临床应用中,应考虑使用小半径荷包线缝合。
{"title":"Novel Technique to Close Stellate Corneal Lacerations.","authors":"Steven E Brooks, Alex Johnson, Emily A Kreuger","doi":"10.1097/ICO.0000000000003730","DOIUrl":"10.1097/ICO.0000000000003730","url":null,"abstract":"<p><strong>Purpose: </strong>The study was performed to evaluate and optimize a novel technique to close stellate corneal lacerations in a wet laboratory environment.</p><p><strong>Materials and methods: </strong>Twenty-one ex vivo porcine eyes with standardized, experimentally created stellate corneal lacerations were assigned to one of three surgical repair techniques. In Group 1 (n = 9), lacerations were closed with simple interrupted sutures only. In Group 2 (n = 7), a large-radius central purse string was used in addition to simple interrupted sutures. In Group 3 (n = 5), a small-radius central purse string was used in addition to simple interrupted sutures. Wound stability was assessed by determining the intraocular pressure (IOP) at which wound leak occurred.</p><p><strong>Results: </strong>Group 3 eyes demonstrated a mean wound leak IOP of 56.1 mm Hg (range 32-90.3) compared with groups 1 and 2, which demonstrated mean wound leak IOPs of 6.4 mm Hg (range 1.9-19) and 13.3 mm Hg (range 2.8-31), respectively. These differences were highly statistically significant ( P  < 0.002 and P  < 0.015, respectively, compared with Group 3).</p><p><strong>Discussion: </strong>The use of a small-radius internal purse-string suture, when combined with simple interrupted sutures, produced a highly effective watertight closure in experimentally created stellate corneal lacerations, significantly outperforming approaches using only interrupted sutures or a large-radius purse string. The use of a small-radius purse-string suture should be considered for clinical use in the repair of stellate corneal lacerations.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"522-524"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter Regarding: Novel Mechanisms Guide Innovative Molecular-Based Therapeutic Strategies for Fuchs Endothelial Corneal Dystrophy. 关于ATF6背景下的Fuchs内皮性角膜营养不良的信函。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2025-01-14 DOI: 10.1097/ICO.0000000000003809
Nektarios Barabutis
{"title":"Letter Regarding: Novel Mechanisms Guide Innovative Molecular-Based Therapeutic Strategies for Fuchs Endothelial Corneal Dystrophy.","authors":"Nektarios Barabutis","doi":"10.1097/ICO.0000000000003809","DOIUrl":"10.1097/ICO.0000000000003809","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e9-e10"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142976822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter Regarding: Validation of the C-DU(KE) Calculator as a Predictor of Outcomes in Patients Enrolled in Steroids for Corneal Ulcer and Mycotic Ulcer Treatment Trials. 关于:C-DU(KE)计算器作为角膜溃疡和真菌性溃疡类固醇治疗试验患者预后预测因子的验证
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-04-01 Epub Date: 2024-10-10 DOI: 10.1097/ICO.0000000000003733
Ricko Wong
{"title":"Letter Regarding: Validation of the C-DU(KE) Calculator as a Predictor of Outcomes in Patients Enrolled in Steroids for Corneal Ulcer and Mycotic Ulcer Treatment Trials.","authors":"Ricko Wong","doi":"10.1097/ICO.0000000000003733","DOIUrl":"10.1097/ICO.0000000000003733","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e8"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cornea
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1